Pharmaceuticals Ultrasector is trading at 27.89 as of the 6th of January 2026; that is 0.61 percent down since the beginning of the trading day. The fund's open price was 28.06. Pharmaceuticals Ultrasector has less than a 19 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 8th of October 2025 and ending today, the 6th of January 2026. Click here to learn more.
The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times the daily performance of the Dow Jones U.S. Pharmaceuticals Ultrasector is traded on NASDAQ Exchange in the United States. More on Pharmaceuticals Ultrasector Profund
Pharmaceuticals Ultrasector Profund [PHPSX] is traded in USA and was established 6th of January 2026. Pharmaceuticals Ultrasector is listed under ProFunds category by Fama And French industry classification. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. This fund at this time has accumulated 10.07 M in assets with minimum initial investment of 15 K. Pharmaceuticals Ultrasector is currently producing year-to-date (YTD) return of 1.85%, while the total return for the last 3 years was -6.99%.
Check Pharmaceuticals Ultrasector Probability Of Bankruptcy
Instrument Allocation
Top Pharmaceuticals Ultrasector Profund Mutual Fund Constituents
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.